Malin Corporation plc (MLC) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic areas, including oncology, immunology, and genetic diseases.
Total Assets Chart for Malin Corporation plc
Malin Corporation plc (MLC) total assets for FY2024 were EUR 198.5M, a 70.2% change from FY2023. Malin Corporation plc's total assets grew from EUR 424.2M in 2015 to EUR 198.5M in 2024 (-53.2% over 9 years). Total assets compound annual growth rate: 5-year CAGR of -6.1%.
Total Assets (Euros)
R&D as % of Revenue
Key Stats
- Market Cap
- €30.28M
- Implied Share Price
- €7.00
- Enterprise Value
- -€31.82M
- Revenue (TTM)
- €41.00M
- EBITDA
- -€2.40M
- Profit Margin
- 0.00%
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price/Book (MRQ)
- 0.16
- Price/Sales (TTM)
- 6.18
- EV/EBITDA
- 186.08
- EV/Revenue
- 6.08
- Dividend Yield
- —
- Book Value
- €8.90
- Free Cash Flow (FY2024)
- -€1.30M
- Free Cash Flow Yield
- -4.29%
Snapshot as of 15th August 2026 — not point-in-time controlled, may lag the live market by a few days.